Link, study suggests
GLP-1 Agonists: A Breakthrough in Reducing Obesity-Related Cancer Risk In 2024, the medical community witnessed a groundbreaking revelation: GLP-1 agonists, widely celebrated for their role in weight loss and blood sugar control, may also significantly reduce the risk of obesity-related cancers. This discovery has sparked hope for millions of patients worldwide,especially those battling type … Read more